Filters
Filters

 

Resource Type
Topic
Show (45)
Cancel
Metrion Biosciences appoints two new Board Directors
March 5, 2018
Read More
Metrion Biosciences awarded £200k funding under Innovate UK Biomedical Catalyst Feasibility Award
February 5, 2018
Read More
Metrion Biosciences acquires rights to small molecule potassium channel inhibitors from Japan Tobacco Inc.
January 29, 2018
Read More
Metrion Biosciences opens £600k investment round through SyndicateRoom to support growth of services business
January 16, 2018
Read More
LifeArc and Metrion Biosciences extend partnership agreement to support LifeArc’s neuroscience small molecule drug discovery programme
July 31, 2017
Read More
Metrion Biosciences appoints Chief Operating Officer and Head of Business Development
May 2, 2017
Read More
Metrion Biosciences and Venomtech announce research collaboration
April 24, 2017
Read More
Metrion Biosciences and Concept Life Sciences Introduce Integrated Ion Channel Drug Discovery Service
March 15, 2017
Read More
Axiogenesis and Metrion Biosciences announce stem cell collaboration
November 7, 2016
Read More
Metrion Biosciences Expands Operations
October 17, 2016
Read More
1 2 3 4 5
Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
Copyright © 2024 Metrion. All rights reserved | Privacy notice | Registered as a company in England and Wales: 09669815 | VAT: GB 219828479
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram